Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Exisulind leads to lower PSA levels according to interim phase II/III data

May 13, 1999

AstraZeneca launches Casodex 80 mg in Japan for treatment of prostate cancer

May 12, 1999

POH enters additional phase II trials

May 12, 1999

Trimelamol analogue available for licensing from CRCT

May 12, 1999

Isis initiates phase II clinical trials of ISIS-2503

May 11, 1999

Non-cysteine-containing FTase inhibitors from Abbott with good oral bioavailability

May 11, 1999

Telomerase inhibitors available for licensing from CRCT

May 11, 1999

Antioxidant di- and triacetic acid derivatives: preparation and use described by L'Oreal

May 11, 1999

Structural Bioinformatics develops antagonists of BcL-2 gene product

May 10, 1999

Licensing opportunity from NIH: recombinant antitumor RNases

May 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...